Skip to main content
. 2017;18(8):2255–2268. doi: 10.22034/APJCP.2017.18.8.2255

Figure 14.

Figure 14

Immunohistochemistry of Part A, Panel (A) sarcoma-180 control (B) 5-FU (C) 20mg/kg and (D) 40mg/kg, showing Bcl-2 (anti-apoptotic protein) expression, in a reducing manner in the above order, marked by box, circle and arrow. Part B exhibits p53 (tumour suppressor protein) expression in an increasing manner in the order panel (A’) sarcoma-180 control (B’) 5-FU (C’) 20 mg/kg b.w and (D’) 40 mg/kg b.w. as above, shown in boxes. Started from day 10 of tumor implantation and continued for 21 days (Magnification: 100 X).